Flufenamic acid inhibits pyroptosis in ischemic flaps via the AMPK-TRPML1-Calcineurin signaling pathway

Liang Chen , Ningning Yang , Kongbin Chen , Yingying Huang , Xian Liu , Gaoxiang Yu , Fulin Wang , Yong Gou , Yi Wang , Xiaolang Lu , Yuqi Wang , Lipeng Zhu , Weiyang Gao , Jian Ding

Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) : tkaf007

PDF (3310KB)
Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) :tkaf007 DOI: 10.1093/burnst/tkaf007
Research Article
research-article
Flufenamic acid inhibits pyroptosis in ischemic flaps via the AMPK-TRPML1-Calcineurin signaling pathway
Author information +
History +
PDF (3310KB)

Abstract

Background: Ischemic injury is a primary cause of distal flap necrosis. Previous studies have shown that Flufenamic acid (FFA) can reduce inflammation, decrease oxidative stress (OS), and promote angiogenesis, suggesting its potential role in protecting flaps from ischemic damage. This study investigated the effects and mechanisms of FFA in enhancing the survival of ischemic flaps. Methods: The viability of ischemic flaps was evaluated using laser doppler blood flow (LDBF) and survival rates. We examined levels of pyroptosis, OS, transcription factor E3 (TFE3)-induced autophagy, and elements of the AMPK-TRPML1-Calcineurin pathway through western blotting (WB), immunofluorescence, molecular docking, cellular thermal shift assay (CETSA) and surface plasmon resonance. Results: The findings suggest that FFA significantly enhances the viability of ischemic flaps. The improvement in flap survival associated with FFA can be attributed to increased autophagy, diminished OS, and the suppression of pyroptosis. Notably, the promotion of autophagy flux and an augmented resistance to OS are instrumental in curbing pyroptosis in these flaps. Activation of TFE3 by FFA promoted autophagy and diminished oxidative damage. The therapeutic effects of FFA were negated when TFE3 levels were decreased using adeno-associated virus (AAV)-TFE3shRNA. Additionally, FFA modified TFE3 activity through the AMPK-TRPML1-Calcineurin pathway. Conclusions: FFA promotes ischemic flap survival via induction of autophagy and suppression of OS by activation of the AMPK-TRPML1-Calcineurin-TFE3 signaling pathway. These findings could have therapeutic implications.

Keywords

FFA / TFE3 / Autophagy / Oxidative stress / Ischemic flaps

Cite this article

Download citation ▾
Liang Chen, Ningning Yang, Kongbin Chen, Yingying Huang, Xian Liu, Gaoxiang Yu, Fulin Wang, Yong Gou, Yi Wang, Xiaolang Lu, Yuqi Wang, Lipeng Zhu, Weiyang Gao, Jian Ding. Flufenamic acid inhibits pyroptosis in ischemic flaps via the AMPK-TRPML1-Calcineurin signaling pathway. Burns & Trauma, 2025, 13 (1) : tkaf007 DOI:10.1093/burnst/tkaf007

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Rao AJ, Kempton SJ, Erickson BJ, Levine BR, Rao VK. Soft tissue reconstruction and flap coverage for revision total knee arthroplasty. J Arthroplast. 2016; 31: 1529-38. https://doi.org/10.1016/j.arth.2015.12.054.

[2]

Lai Y, Yang N, Shi D, Ma X, Huang Y, Lu J, et al. Puerarin enhances TFEB-mediated autophagy and attenuates ROS-induced pyroptosis after ischemic injury of random-pattern skin flaps. Eur J Pharmacol. 2024; 974: 176621. https://doi.org/10.1016/j.ejphar.2024.176621.

[3]

Lou J, Wang X, Zhang H, Yu G, Ding J, Zhu X, et al. Inhibition of PLA2G4E/cPLA2 promotes survival of random skin flaps by alleviating lysosomal membrane permeabilization-induced necroptosis. Autophagy. 2022; 18: 1841-63. https://doi.org/10.1080/15548627.2021.2002109.

[4]

Yang C, Wang J, Chen L, Xu T, Ming R, Hu Z, et al. Tongluo Shenggu capsule promotes angiogenesis to ameliorate glucocorticoid-induced femoral head necrosis via upregulating VEGF signaling pathway. Phytomedicine. 2023; 110: 154629. https://doi.org/10.1016/j.phymed.2022.154629.

[5]

Kim Y-W, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 2013; 91: 323-8. https://doi.org/10.1007/s00109-013-1007-3.

[6]

Sanz AB, Sanchez-Niño MD, Ramos AM, Ortiz A.Regulated cell death pathways in kidney disease. Nat Rev Nephrol. 2023; 19: 281-99. https://doi.org/10.1038/s41581-023-00694-0.

[7]

Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535: 153-8. https://doi.org/10.1038/nature18629.

[8]

Fu J, Wu H. Structural mechanisms of NLRP3 Inflammasome assembly and activation. Annu Rev Immunol. 2023; 41: 301-16. https://doi.org/10.1146/annurev-immunol-081022-021207.

[9]

Sharma BR, Kanneganti T-D. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021; 22: 550-9. https://doi.org/10.1038/s41590-021-00886-5.

[10]

Lee J-H, You H-J, Lee T-Y, Kang HJ. Current status of experimental animal skin flap models: ischemic preconditioning and molecular factors. Int J Mol Sci. 2022; 23: 5234. https://doi.org/10.3390/ijms23095234.

[11]

Gao M, Zhang X, Wang Y, Liu Q, Yu F, Huang Y, et al. Sequential detection of superoxide anion and hydrogen Polysulfides under hypoxic stress via a spectral-response-separated fluorescent probe functioned with a nitrobenzene derivative. Anal Chem. 2019; 91: 7774-81. https://doi.org/10.1021/acs.analchem.9b01189.

[12]

Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K. ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol. 2022; 13: 1039241. https://doi.org/10.3389/fimmu.2022.1039241.

[13]

Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014; 10: 9-17. https://doi.org/10.1038/nchembio.1416.

[14]

Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014; 20: 460-73. https://doi.org/10.1089/ars.2013.5371.

[15]

Tang C, Livingston MJ, Liu Z, Dong Z. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020; 16: 489-508. https://doi.org/10.1038/s41581-020-0309-2.

[16]

Napoletano F, Baron O, Vandenabeele P, Mollereau B, Fanto M. Intersections between regulated cell death and autophagy. Trends Cell Biol. 2019; 29: 323-38. https://doi.org/10.1016/j.tcb.2018.12.007.

[17]

Liu X, Li Z, Liu H, Zhu Y, Xia D, Wang S, et al. Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway. Stem Cell Res Ther. 2019; 10: 213. https://doi.org/10.1186/s13287-019-1321-y.

[18]

Ni K, Che B, Gu R, Wang C, Xu H, Li H, et al. BitterDB database analysis plus cell stiffness screening identify flufenamic acid as the most potent TAS2R14-based relaxant of airway smooth muscle cells for therapeutic bronchodilation. Theranostics. 2024; 14: 1744-63. https://doi.org/10.7150/thno.92492.

[19]

Jung ES, Suh K, Han J, Kim H, Kang H-S, Choi W-S, et al. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway. Aging Cell. 2022; 21: e13623. https://doi.org/10.1111/acel.13623.

[20]

Ge R, Hu L, Tai Y, Xue F, Yuan L, Wei G, et al. Flufenamic acid promotes angiogenesis through AMPK activation. Int J Oncol. 2013; 42: 1945-50. https://doi.org/10.3892/ijo.2013.1891.

[21]

Paquette M, El-Houjeiri L, Zirden C, Puustinen P, Blanchette P, Jeong H, et al. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021; 17: 3957-75. https://doi.org/10.1080/15548627.2021.1898748.

[22]

Chenu C, Adlanmerini M, Boudou F, Chantalat E, Guihot A-L, Toutain C, et al. Testosterone prevents cutaneous ischemia and necrosis in males through complementary estrogenic and androgenic actions. Arterioscler Thromb Vasc Biol. 2017; 37: 909-19. https://doi.org/10.1161/ATVBAHA.117.309219.

[23]

Tsai K-K, Yen C-F, Chu Y-H, Wang H-W. Using dynamic analysis of laser-Doppler blood flowmetry to measure nasal mucosa bloody flow in postural changes. Rhinology. 2012; 50: 376-80. https://doi.org/10.4193/Rhino10.134.

[24]

Wahyudi H, Reynolds AA, Li Y, Owen SC, Yu SM. Targeting collagen for diagnostic imaging and therapeutic delivery. J Control Release. 2016; 240: 323-31. https://doi.org/10.1016/j.jconrel.2016.01.007.

[25]

Qu J, Qiu B, Zhang Y, Hu Y, Wang Z, Guan Z, et al. The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling. Signal Transduct Target Ther. 2023; 8: 424. https://doi.org/10.1038/s41392-023-01666-3.

[26]

Puertollano R, Ferguson SM, Brugarolas J, Ballabio A. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J. 2018; 37: e98804. https://doi.org/10.15252/embj.201798804.

[27]

Cheng X, Liang J, Wu D, Guo X, Cao H, Zhang C, et al. Blunting ROS/TRPML1 pathway protects AFB1-induced porcine intestinal epithelial cells apoptosis by restoring impaired autophagic flux. Ecotoxicol Environ Saf. 2023; 257: 114942. https://doi.org/10.1016/j.ecoenv.2023.114942.

[28]

Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, et al. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2023; 7: 13-25. https://doi.org/10.1016/S2352-4642(22)00283-8.

[29]

Mazdeyasna S, Huang C, Paranzino AB, Mohtasebi M, Cheng Q, Wong L, et al. Intraoperative optical and fluorescence imaging of blood flow distributions in mastectomy skin flaps for identifying ischemic tissues. Plast Reconstr Surg. 2022; 150: 282-7. https://doi.org/10.1097/PRS.0000000000009333.

[30]

Yu G, Chen Y, Yang N, Zhang H, Zhang X, Geng Y, et al. Apoptotic bodies derived from fibroblast-like cells in subcutaneous connective tissue inhibit Ferroptosis in ischaemic flaps via the miR-339-5p/KEAP1/Nrf2 Axis. Adv Sci (Weinh). 2024; 11: e2307238. https://doi.org/10.1002/advs.202307238.

[31]

Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol basis Dis. 2020; 1866: 165768. https://doi.org/10.1016/j.bbadis.2020.165768.

[32]

Pongkorpsakol P, Satitsri S, Wongkrasant P, Chittavanich P, Kittayaruksakul S, Srimanote P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of vibrio cholerae infection through NF-κB inhibition and AMPK activation. Eur J Pharmacol. 2017; 798: 94-104. https://doi.org/10.1016/j.ejphar.2017.01.026.

[33]

Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024; 187: 235-56. https://doi.org/10.1016/j.cell.2023.11.044.

[34]

Oleck NC, Gu C, Pyfer BJ, Phillips BT. Defining mastectomy skin flap necrosis: a systematic review of the literature and a call for standardization. Plast Reconstr Surg. 2022; 149: 858e-66. https://doi.org/10.1097/PRS.0000000000008983.

[35]

Djulbegovic MB, Uversky VN. Ferroptosis-an iron-and disorder-dependent programmed cell death. Int J Biol Macromol. 2019; 135: 1052-69. https://doi.org/10.1016/j.ijbiomac.2019.05.221.

[36]

Yang N, Yu G, Lai Y, Zhao J, Chen Z, Chen L, et al. A snake cathelicidin enhances transcription factor EB-mediated autophagy and alleviates ROS-induced pyroptosis after ischaemia-reperfusion injury of island skin flaps. Br J Pharmacol. 2024; 181: 1068-90. https://doi.org/10.1111/bph.16268.

[37]

Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis. Gut. 2023; 72: 2272-85. https://doi.org/10.1136/gutjnl-2023-329543.

[38]

Li L, Xing C, Zhou J, Niu L, Luo B, Song M, et al. Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis. Part Fibre Toxicol. 2021; 18: 10. https://doi.org/10.1186/s12989-021-00403-4.

[39]

Li Z, Wu F, Xu D, Zhi Z, Xu G. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions. Biomed Pharmacother. 2019; 109: 2014-21. https://doi.org/10.1016/j.biopha.2018.08.159.

[40]

Zhang S, Hama Y, Mizushima N. The evolution of autophagy proteins-diversification in eukaryotes and potential ancestors in prokaryotes. J Cell Sci. 2021; 134: jcs233742. https://doi.org/10.1242/jcs.233742.

[41]

Sambri I, Ferniani M, Campostrini G, Testa M, Meraviglia V, de Araujo MEG, et al. RagD auto-activating mutations impair MiT/TFE activity in kidney tubulopathy and cardiomyopathy syndrome. Nat Commun. 2023; 14: 2775. https://doi.org/10.1038/s41467-023-38428-2.

[42]

Ferrari V, Cristofani R, Cicardi ME, Tedesco B, Crippa V, Chierichetti M, et al. Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells. Neuropathol Appl Neurobiol. 2022; 48: e12818. https://doi.org/10.1111/nan.12818.

[43]

Kauffman EC, Lang M, Rais-Bahrami S, Gupta GN, Wei D, Yang Y, et al. Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion. BMC Cancer. 2019; 19: 917. https://doi.org/10.1186/s12885-019-6096-0.

[44]

Mitani F, Lin J, Sakamoto T, Uehara R, Hikita T, Yoshida T, et al. Asteltoxin inhibits extracellular vesicle production through AMPK/mTOR-mediated activation of lysosome function. Sci Rep. 2022; 12: 6674. https://doi.org/10.1038/s41598-022-10692-0.

[45]

Malik N, Ferreira BI, Hollstein PE, Curtis SD, Trefts E, Weiser Novak S, et al. Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1. Science. 2023; 380:eabj5559. https://doi.org/10.1126/science.abj5559.

[46]

Mossmann D, Park S, Hall MN.mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018; 18: 744-57. https://doi.org/10.1038/s41568-018-0074-8.

[47]

Peng W, Wong YC, Krainc D. Mitochondria-lysosome contacts regulate mitochondrial Ca2+ dynamics via lysosomal TRPML1. Proc Natl Acad Sci USA. 2020; 117: 19266-75. https://doi.org/10.1073/pnas.2003236117.

[48]

Yang J, Kim W, Kim DR. Autophagy in cell survival and death. Int J Mol Sci. 2023; 24: 4744. https://doi.org/10.3390/ijms24054744.

[49]

Lou J, Zhang H, Qi J, Xu Y, Wang X, Jiang J, et al. Cyclic helix B peptide promotes random-pattern skin flap survival via TFE3-mediated enhancement of autophagy and reduction of ROS levels. Br J Pharmacol. 2022; 179: 301-21. https://doi.org/10.1111/bph.15702.

[50]

Chen S, Ma J, Yin P, Liang F. The landscape of mitophagy in sepsis reveals PHB1 as an NLRP3 inflammasome inhibitor. Front Immunol. 2023; 14: 1188482. https://doi.org/10.3389/fimmu.2023.1188482.

[51]

Zhang D, Jin C, Han T, Chen J, Ali Raza M, Li B, et al. Sinomenine promotes flap survival by upregulating eNOS and eNOS-mediated autophagy via PI3K/AKT pathway. Int Immunopharmacol. 2023; 116: 109752. https://doi.org/10.1016/j.intimp.2023.109752.

[52]

Łuczak A, Madej M, Kasprzyk A, Doroszko A. Role of the eNOS uncoupling and the nitric oxide metabolic pathway in the pathogenesis of autoimmune rheumatic diseases. Oxidative Med Cell Longev. 2020; 2020: 1417981-15. https://doi.org/10.1155/2020/1417981.

[53]

Rochette L, Lorin J, Zeller M, Guilland J-C, Lorgis L, Cottin Y, et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther. 2013; 140: 239-57. https://doi.org/10.1016/j.pharmthera.2013.07.004.

[54]

Chen J, Jiang Z, Liu X, Wang K, Fan W, Chen T, et al. Berberine promotes the viability of random skin flaps via the PI3K/Akt/eNOS signaling pathway. Phytother Res. 2023; 37: 424- 37. https://doi.org/10.1002/ptr.7621.

[55]

Daiber A, Xia N, Steven S, Oelze M, Hanf A, Kröller-Schön S, et al. New therapeutic implications of endothelial nitric oxide synthase (eNOS) function/dysfunction in cardiovascular disease. Int J Mol Sci. 2019; 20: 187. https://doi.org/10.3390/ijms20010187.

[56]

Wada S, Neinast M, Jang C, Ibrahim YH, Lee G, Babu A, et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 2016; 30: 2551-64. https://doi.org/10.1101/gad.287953.116.

[57]

Zhao J, Gao G, Ding J, Liu W, Wang T, Zhao L, et al. Astragaloside I promotes Lipophagy and mitochondrial biogenesis to improve Hyperlipidemia by regulating Akt/mTOR/TFEB pathway. J Agric Food Chem. 2024; 72: 21548-59. https://doi.org/10.1021/acs.jafc.4c03172.

PDF (3310KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉